Useless until proven effective: the clinical utility of preemptive pharmacogenetic testing.
1] Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta Georgia, USA [2] Department of Clinical Genetics, VU Medical Center, Amsterdam, The Netherlands.
A C J W
AC
Janssens
Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Center for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, USA.
P A
PA
Deverka
D003362:Cost-Benefit Analysis; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics